Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors



Status:Recruiting
Conditions:Liver Cancer, Liver Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Brain Cancer, Brain Cancer, Endocrine
Therapuetic Areas:Endocrinology, Oncology
Healthy:No
Age Range:2 - 30
Updated:4/4/2019
Start Date:May 8, 2017
End Date:June 30, 2021

Use our guide to learn which trials are right for you!

Phase 2 Trial of XL184 (Cabozantinib) an Oral Small-Molecule Inhibitor of Multiple Kinases, in Children and Young Adults With Refractory Sarcomas, Wilms Tumor, and Other Rare Tumors

This phase II trial studies how well cabozantinib-s-malate works in treating younger patients
with sarcomas, Wilms tumor, or other rare tumors that have come back, do not respond to
therapy, or are newly diagnosed. Cabozantinib-s-malate may stop the growth of tumor cells by
blocking some of the enzymes needed for tumor growth and tumor blood vessel growth.

PRIMARY OBJECTIVES:

I. To determine the objective response rate (complete response + partial response) of
cabozantinib-s-malate (XL184) in children and young adults.

II. To estimate whether XL184 therapy either improves the disease control rate at 4 months in
patients with recurrent measurable osteosarcoma as compared to a historical Childrens
Oncology Group (COG) experience or produces an objective response rate.

SECONDARY OBJECTIVES:

I. To further define XL184 related toxicities in pediatric, adolescent and young adult
patients.

II. To further define XL184 pharmacokinetics in the pediatric and adolescent patients.

III. To estimate 1-year time to progression, progression free survival (PFS) and overall
survival for each stratum, and if feasible to compare to historical controls.

EXPLORATORY OBJECTIVES:

I. To assess the effect of XL184 on patients' immune cell subsets. II. To obtain tumor tissue
(snap frozen, formalin-fixed and paraffin-embedded [FFPE] blocks, or unstained slides) from
diagnosis, recurrence, or both, for possible future studies.

OUTLINE:

Patients receive cabozantinib-s-malate orally (PO) once daily (QD) on days 1-28. Courses
repeat every 28 days in the absence of disease progression or unacceptable toxicity.

After completion of study treatment, patients are followed up at 30 days, every 6 months for
1 year and then annually for up to 5 years.

Inclusion Criteria:

- Upper age limit of =< 18 years of age for medullary thyroid carcinoma (MTC), renal
cell carcinoma (RCC) and hepatocellular carcinoma (HCC)

- Patients must have a body surface area >= 0.35 m^2

- Patients must have recurrent or refractory disease, or newly diagnosed disease with no
known curative therapy or therapy proven to prolong survival with an acceptable
quality of life; patients must have had histologic verification of one of the
malignancies listed below at original diagnosis or at relapse:

- Ewing sarcoma

- Rhabdomyosarcoma (RMS)

- Non-rhabdomyosarcoma soft tissue sarcomas (STS) including microphthalmia
transcription factor associated STS (alveolar soft part sarcoma [ASPS] and clear
cell sarcoma [CCS])

- Osteosarcoma

- Wilms tumor

- Rare tumors

- Medullary thyroid carcinoma (MTC)

- Renal cell carcinoma (RCC)

- Hepatocellular carcinoma (HCC)

- Hepatoblastoma

- Adrenocortical carcinoma

- Pediatric solid tumors (including central nervous system [CNS] tumors) with
known molecular alterations in the targets of XL184 (i.e., MET
amplification, overexpression, activating mutation, MET translocation, MET
exon skipping mutations, activating RET mutations, RET rearrangement,
overexpression or activation of AXL); documentation of the alteration from a
Clinical Laboratory Improvement Act (CLIA) certified laboratory will be
required

- Note: Documentation of any known tumor molecular alterations and RET
mutation status for patients with MTC (germline) must be uploaded via
the RAVE system

- Patients must have radiographically measurable disease; measurable disease is defined
as the presence of at least one lesion on magnetic resonance imaging (MRI) or computed
tomography (CT) scan that can be accurately measured with the longest diameter a
minimum of 10 mm in at least one dimension (CT scan slice thickness no greater than 5
mm)

- Note: The following do NOT qualify as measurable disease:

- Malignant fluid collections (e.g., ascites, pleural effusions)

- Bone marrow infiltration

- Lesions only detected by nuclear medicine studies (e.g., bone, gallium or
positron emission tomography [PET] scans)

- Elevated tumor markers in plasma or cerebrospinal fluid (CSF)

- Previously radiated lesions that have not demonstrated clear progression
post radiation

- Leptomeningeal lesions that do not meet the measurement parameters noted
above

- Patients must have a Lansky or Karnofsky performance status score of >= 50,
corresponding to Eastern Cooperative Oncology Group (ECOG) categories 0, 1 or 2; use
Karnofsky for patients > 16 years of age and Lansky for patients =< 16 years of age;
patients who are unable to walk because of paralysis, but who are up in a wheelchair,
will be considered ambulatory for the purpose of assessing the performance score

- Patients must have fully recovered from the acute toxic effects of all prior
chemotherapy, immunotherapy, or radiotherapy prior to entering this study

- Patients with solid tumors must not have received myelosuppressive chemotherapy within
3 weeks of enrollment onto this study (6 weeks if prior nitrosourea)

- At least 7 days must have elapsed since the completion of therapy with a growth
factor. At least 14 days must have elapsed after receiving pegfilgrastim

- Anti-cancer agents not known to be myelosuppressive (e.g. not associated with reduced
platelet or absolute neutrophil count [ANC] counts): >= 7 days after the last dose of
agent

- Antibodies: >= 21 days must have elapsed from infusion of last dose of antibody, and
toxicity related to prior antibody therapy must be recovered to grade =< 1

- >= 2 weeks must have elapsed since local palliative radiation therapy (XRT) (small
port); >= 6 weeks must have elapsed since treatment with therapeutic doses of
M-Iodobenzylguanidine (MIBG); >= 3 months must have elapsed if prior craniospinal XRT
was received, if >= 50% of the pelvis was irradiated, or if total-body irradiation
(TBI) was received; >= 6 weeks must have elapsed if other substantial bone marrow
irradiation was given

- Subjects should not have any clinically relevant ongoing complications from prior
radiation therapy (i.e., radiation esophagitis or other inflammation of the
viscera)

- No evidence of active graft versus (vs.) host disease and >= 2 months must have
elapsed since transplant

- Not previously received XL184 or another MET/HGF inhibitor (tivantinib or crizotinib);
there are no limits on number of prior therapeutic regimens; patients who have been
treated with prior VEGF pathway, or RET inhibitors (except XL184) may be eligible

- Peripheral absolute neutrophil count (ANC) >= 1000/uL for patients with solid tumors
without bone marrow involvement

- Platelet count >= 100,000/uL (transfusion independent, defined as not receiving
platelet transfusions within a 7 day period prior to enrollment) for patients with
solid tumors without bone marrow involvement

- Hemoglobin >= 8.0 g/dL (may receive red blood cell [RBC] transfusions) for patients
with solid tumors without bone marrow involvement

- Peripheral absolute neutrophil count (ANC) >= 750/uL for patients with solid tumors
and known bone marrow metastatic disease

- Platelet count >= 50,000/uL for patients with solid tumors and known bone marrow
metastatic disease

- Hemoglobin >= 8.0 g/dL for patients with solid tumors and known bone marrow metastatic
disease

- Transfusions are permitted to meet both the platelet and hemoglobin criteria; patients
must not be known to be refractory to red blood cell or platelet transfusions

- Creatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70
mL/min/1.73 m^2 or a serum creatinine based on age/gender as follows:

- 2 to < 6 years of age

- Male and female: 0.8 (maximum serum creatinine [mg/dL])

- 6 to < 10 years of age

- Male and female: 1 (maximum serum creatinine [mg/dL])

- 10 to < 13 years of age

- Male and female: 1.2 (maximum serum creatinine [mg/dL])

- 13 to < 16 years of age

- Male 1.5 (maximum serum creatinine [mg/dL])

- Female: 1.4 (maximum serum creatinine [mg/dL])

- >= 16 years of age

- Male: 1.7 (maximum serum creatinine [mg/dL])

- Female: 1.4 (maximum serum creatinine [mg/dL])

- Urine protein: =< 30 mg/dl in urinalysis or =< 1+ on dipstick, unless quantitative
protein is < 1000 mg in a 24 hour (h) urine sample

- Total bilirubin =< 1.5 x upper limit of normal (ULN) for age

- Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< 135
U/L (3 x ULN) (for the purpose of this study, the ULN for SGPT is 45 U/L)

- Serum albumin >= 2.8 g/dL

- No history of congenital prolonged corrected QT (QTc) syndrome, New York Heart
Association (NYHA) class III or IV congestive heart failure (CHF)

- No clinically significant cardiac arrhythmias, stroke or myocardial infarction within
6 months prior to enrollment

- QTc =< 480 msec; Note: Patients with grade 1 prolonged QTc (450- 480 msec) at the time
of study enrollment should have correctable causes of prolonged QTc addressed if
possible (i.e., electrolytes, medications)

- Patients with a known seizure disorder who are receiving non-enzyme inducing
anticonvulsants and have well-controlled seizures may be enrolled

- CNS toxicity =< grade 2 with the exception of decreased tendon reflex (DTR); any grade
of DTR is eligible

- A blood pressure (BP) =< the 95th percentile for age, height, and gender for pediatric
patients < 18 years old and =< 140/90 mmHg for patients >= 18 years old; patients
should not be receiving medication for treatment of hypertension (except patients with
Wilms tumor and RCC who may be eligible if on stable doses of no more than one
anti-hypertensive medication with a baseline BP =< ULN for pediatric patients and =<
140/90 for adult patients); please note that 3 serial blood pressures should be
obtained and averaged to determine baseline BP

- International normalized ratio (INR) =< 1.5

- Serum amylase =< 1.5 ULN

- Serum lipase =< 1.5 ULN

Exclusion Criteria:

- Pregnant or breast-feeding women will not be entered on this study; pregnancy tests
must be obtained in girls who are post-menarchal; males or females of reproductive
potential may not participate unless they have agreed to use two methods of birth
control- a medically accepted barrier method of contraceptive method (e.g., male or
female condom) and a second effective method of birth control-during protocol therapy
and for at least 4 months after the last dose of XL184; abstinence is an acceptable
method of birth control

- Growth factors that support platelet or white cell number or function must not have
been administered within the 7 days prior to enrollment (14 days if pegfilgrastim)

- Patients requiring corticosteroids who have not been on a stable or decreasing dose of
corticosteroid for the 7 days prior to enrollment are not eligible; if used to modify
immune adverse events related to prior therapy, >= 14 days must have elapsed since
last dose of corticosteroid

- Previous treatment with XL184 (cabozantinib) or another MET/HGF inhibitor (tivantinib,
crizotinib)

- Patients who are currently receiving another investigational drug are not eligible

- Patients who are currently receiving other anti-cancer agents are not eligible

- Patients who are receiving cyclosporine, tacrolimus or other agents to prevent either
graft-versus-host disease post bone marrow transplant or organ rejection
post-transplant are not eligible for this trial

- Patients must not be receiving any of the following potent CYP3A4 inducers or
inhibitors: erythromycin, clarithromycin, ketoconazole, azithromycin, itraconazole,
grapefruit juice or St. John's wort

- Concomitant anticoagulation with oral anticoagulants (e.g., warfarin, direct thrombin,
and Factor Xa inhibitors) or platelet inhibitors (e.g., clopidogrel) are prohibited

- Note: Low-dose aspirin for cardioprotection (per local applicable guidelines) and
low dose, low molecular weight heparins (LMWH) are permitted; anticoagulation
with therapeutic doses of LMWH is allowed in subjects without radiographic
evidence of brain metastasis, who are on a stable dose of LMWH for at least 6
weeks before first dose of study treatment, and who have had no complications
from a thromboembolic event or the anticoagulation regimen

- Patients must not have received enzyme-inducing anticonvulsants within 14 days prior
to enrollment

- Patients who are receiving drugs that prolong QTc are not eligible

- Patients who are unable to swallow intact tablets are not eligible

- Patients who have an uncontrolled infection are not eligible

- Patients who in the opinion of the investigator may not be able to comply with the
safety monitoring requirements of the study are not eligible

- Patients with active bleeding are not eligible; specifically, no clinically
significant gastrointestinal (GI) bleeding, GI perforation, intra-abdominal abscess or
fistula for 6 months prior to enrollment, no hemoptysis or other signs of pulmonary
hemorrhage for 3 months prior to enrollment; patients with evidence of an acute
intracranial or intratumoral hemorrhage on CT or MRI are not eligible (patients with
evidence of resolving hemorrhage will be eligible); in patients with CNS tumors, an
MRI with ECHO gradient sequences would be required to exclude presence of petechial
hemorrhages

- Patients who have had or are planning to have the following invasive procedures are
not eligible:

- Major surgical procedure, laparoscopic procedure, or open biopsy within 28 days
prior to enrollment

- Central line placement or subcutaneous port placement is not considered major
surgery but must be placed at least 3 days prior to enrollment for external lines
(e.g., Hickman or Broviac catheter, peripherally inserted central catheter
[PICC]) and at least 7 days prior to enrollment for a subcutaneous port

- Core biopsy within 7 days prior to enrollment

- Fine needle aspirate within 7 days prior to enrollment

- Surgical or other wounds must be adequately healed prior to enrollment

- NOTE: For purposes of this study, bone marrow aspirate and biopsy are not
considered surgical procedures and therefore are permitted within 14 days prior
to start of protocol therapy

- Patients who have had significant traumatic injury within 28 days prior to enrollment
are not eligible

- Patients with any medical or surgical conditions that would interfere with
gastrointestinal absorption of the study drug are not eligible
We found this trial at
135
sites
1200 Pleasant St
Des Moines, Iowa 50309
(515) 241-6212
Principal Investigator: Samantha L. Mallory
Phone: 515-241-6727
Iowa Methodist Medical Center Iowa Methodist Medical Center was established in 1901 in a single...
?
mi
from
Des Moines, IA
Click here to add this to my saved trials
1600 7th Avenue
Birmingham, Alabama 35233
(205) 638-9100
Principal Investigator: Gregory K. Friedman
Children's Hospital of Alabama Children
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
666 Elm Street
Buffalo, New York 14263
(716) 845-2300
Principal Investigator: Clare J. Twist
Phone: 800-767-9355
Roswell Park Cancer Institute Welcome to Roswell Park Cancer Institute (RPCI), America's first cancer center...
?
mi
from
Buffalo, NY
Click here to add this to my saved trials
1 South Prospect Street
Burlington, Vermont 05401
802-656-8990
Principal Investigator: Jessica L. Heath
?
mi
from
Burlington, VT
Click here to add this to my saved trials
1300 Jefferson Park Avenue
Charlottesville, Virginia 22908
434-243-6784
Principal Investigator: William C. Petersen
Phone: 434-243-6303
University of Virginia Cancer Center We are fortunate in having state of the art clinical...
?
mi
from
Charlottesville, VA
Click here to add this to my saved trials
3333 Burnet Avenue # Mlc3008
Cincinnati, Ohio 45229
 1-513-636-4200 
Principal Investigator: James I. Geller
Cincinnati Children's Hospital Medical Center Patients and families from across the region and around the...
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
11100 Euclid Avenue
Cleveland, Ohio 44106
(216) 844-1000
Principal Investigator: John J. Letterio
Phone: 216-844-5437
Rainbow Babies and Children's Hospital UH Rainbow Babies & Children’s Hospital is a 244-bed, full-service...
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
700 Childrens Drive
Columbus, Ohio 43205
(616) 722-2000
Principal Investigator: Mark A. Ranalli
Nationwide Children's Hospital At Nationwide Children’s, we are creating the future of pediatric health care....
?
mi
from
Columbus, OH
Click here to add this to my saved trials
7777 Forest Ln # C840
Dallas, Texas 75230
(972) 566-7000
Principal Investigator: Stanton C. Goldman
Phone: 972-566-5588
Medical City Dallas Hospital If you have concerns for your health, that of a family...
?
mi
from
Dallas, TX
Click here to add this to my saved trials
1200 Pleasant Street
Des Moines, Iowa 50309
(515) 241-KIDS
Principal Investigator: Samantha L. Mallory
Blank Children's Hospital Blank Children's Hospital is completely dedicated to meeting the unique health care...
?
mi
from
Des Moines, IA
Click here to add this to my saved trials
282 Washington St
Hartford, Connecticut 06106
(860) 545-9000
Principal Investigator: Michael S. Isakoff
Phone: 800-579-7822
Connecticut Children's Medical Center Connecticut Children’s Medical Center is a nationally recognized, 187-bed not-for-profit children’s...
?
mi
from
Hartford, CT
Click here to add this to my saved trials
2500 N State St
Jackson, Mississippi 39216
(601) 984-1000
Principal Investigator: Anderson (Andy) B. Collier
Phone: 601-815-6700
University of Mississippi Medical Center The University of Mississippi Medical Center, located in Jackson, is...
?
mi
from
Jackson, MS
Click here to add this to my saved trials
4650 Sunset Blvd
Los Angeles, California 90027
 (323) 660-2450
Principal Investigator: Leo Mascarenhas
Phone: 323-361-4110
Childrens Hospital Los Angeles Children's Hospital Los Angeles is a 501(c)(3) nonprofit hospital for pediatric...
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
262 Danny Thomas Pl
Memphis, Tennessee 38105
(901) 495-3300
Principal Investigator: Wayne L. Furman
Phone: 866-278-5833
St. Jude Children's Research Hospital St. Jude is unlike any other pediatric treatment and research...
?
mi
from
Memphis, TN
Click here to add this to my saved trials
601 Children's Lane
Norfolk, Virginia 23507
(757) 668-7000
Principal Investigator: Eric J. Lowe
Phone: 757-668-7243
Children's Hospital of The King's Daughters Children
?
mi
from
Norfolk, VA
Click here to add this to my saved trials
747 52nd St
Oakland, California 94609
(510) 428-3000
Principal Investigator: Carla B. Golden
Children's Hospital and Research Center Oakland For nearly 100 years, Children's Hospital & Research Center...
?
mi
from
Oakland, CA
Click here to add this to my saved trials
1201 W La Veta Ave
Orange, California 92868
(714) 997-3000
Principal Investigator: Elyssa M. Rubin
Phone: 714-997-3000
Children's Hospital of Orange County For more than 45 years, CHOC Children’s has been steadfastly...
?
mi
from
Orange, CA
Click here to add this to my saved trials
5153 North 9th Avenue
Pensacola, Florida 32504
(850) 505-4700
Principal Investigator: Scott M. Bradfield
Nemours Children's Clinic - Pensacola Nemours Children’s Clinic, Pensacola serves children and families in northwest...
?
mi
from
Pensacola, FL
Click here to add this to my saved trials
530 Northeast Glen Oak Avenue
Peoria, Illinois 61603
(309) 624-4945
Principal Investigator: Jaime M. Libes
Phone: 888-226-4343
Saint Jude Midwest Affiliate The Jim and Trudy Maloof St. Jude Midwest Affiliate Clinic was...
?
mi
from
Peoria, IL
Click here to add this to my saved trials
South 34th Street
Philadelphia, Pennsylvania 19104
 215-590-1000
Principal Investigator: Elizabeth Fox
Phone: 800-411-1222
Children's Hospital of Philadelphia Since its start in 1855 as the nation's first hospital devoted...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
4401 Penn Avenue
Pittsburgh, Pennsylvania 15224
412-692-5325
Principal Investigator: Jean M. Tersak
Phone: 412-692-5573
Children's Hospital of Pittsburgh of UPMC UPMC is one of the leading nonprofit health systems...
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
3181 Southwest Sam Jackson Park Road
Portland, Oregon 97239
503 494-8311
Principal Investigator: Linda C. Stork
Phone: 503-494-1080
Oregon Health and Science University In 1887, the inaugural class of the University of Oregon...
?
mi
from
Portland, OR
Click here to add this to my saved trials
3020 Childrens way
San Diego, California 92123
(858) 576-1700
Principal Investigator: William D. Roberts
Rady Children's Hospital - San Diego Rady Children's Hospital-San Diego is the region’s pediatric medical...
?
mi
from
San Diego, CA
Click here to add this to my saved trials
1600 Rockland Road
Wilmington, Delaware 19803
(302) 651-4200
Principal Investigator: Scott M. Bradfield
Phone: 302-651-6884
Alfred I. duPont Hospital for Children Nemours began more than 70 years ago with the...
?
mi
from
Wilmington, DE
Click here to add this to my saved trials
Anaheim, California 92806
Principal Investigator: Robert M. Cooper
Phone: 626-564-3455
?
mi
from
Anaheim, CA
Click here to add this to my saved trials
Anchorage, Alaska 99508
Principal Investigator: Brenda J. Wittman
Phone: 907-212-6871
?
mi
from
Anchorage, AK
Click here to add this to my saved trials
1540 East Hospital Drive
Ann Arbor, Michigan 48109
(877) 475-6688
Principal Investigator: Rajen Mody
Phone: 800-865-1125
C S Mott Children's Hospital Behind the doors of C.S. Mott Children's Hospital there exist...
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Atlanta, Georgia 30322
Principal Investigator: William T. Cash
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
13123 E 16th Ave
Aurora, Colorado 80045
(720) 777-1234
Principal Investigator: Margaret E. Macy
Phone: 720-777-6672
Children's Hospital Colorado At Children's Hospital Colorado, we see more, treat more and heal more...
?
mi
from
Aurora, CO
Click here to add this to my saved trials
2401 W Belvedere Ave
Baltimore, Maryland 21215
(410) 601-9000
Principal Investigator: Jason M. Fixler
Phone: 410-601-5864
Sinai Hospital of Baltimore Sinai Hospital of Baltimore provides a broad array of high-quality, cost-effective...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
401 North Broadway
Baltimore, Maryland 21287
410-955-5000
Principal Investigator: Christine A. Pratilas
Phone: 410-955-8804
Johns Hopkins University-Sidney Kimmel Cancer Center The name Johns Hopkins has become synonymous with excellence...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
489 State St
Bangor, Maine 04401
(207) 973-7000
Principal Investigator: Nadine P. SantaCruz
Phone: 207-973-4274
Eastern Maine Medical Center Located in Bangor, Eastern Maine Medical Center (EMMC) serves communities throughout...
?
mi
from
Bangor, ME
Click here to add this to my saved trials
Bellflower, California 90706
Principal Investigator: Robert M. Cooper
Phone: 626-564-3455
?
mi
from
Bellflower, CA
Click here to add this to my saved trials
9000 Rockville Pike
Bethesda, Maryland 20892
301-496-2563
Principal Investigator: Brigitte C. Widemann
Phone: 800-411-1222
National Institutes of Health Clinical Center The National Institutes of Health (NIH) Clinical Center in...
?
mi
from
Bethesda, MD
Click here to add this to my saved trials
100 E Idaho St
Boise, Idaho 83712
(208) 381-2711
Principal Investigator: Eugenia Chang
Phone: 208-381-3376
Saint Luke's Mountain States Tumor Institute For more than 100 years, St. Luke
?
mi
from
Boise, ID
Click here to add this to my saved trials
450 Brookline Ave
Boston, Massachusetts 2215
617-632-3000
Principal Investigator: Suzanne Shusterman
Phone: 877-442-3324
Dana-Farber Cancer Institute Since it’s founding in 1947, Dana-Farber has been committed to providing adults...
?
mi
from
Boston, MA
Click here to add this to my saved trials
55 Fruit St
Boston, Massachusetts 02114
(617) 724-4000
Principal Investigator: Suzanne Shusterman
Phone: 877-726-5130
Massachusetts General Hospital Cancer Center An integral part of one of the world
?
mi
from
Boston, MA
Click here to add this to my saved trials
Brewer, Maine 04412
Principal Investigator: Nadine P. SantaCruz
Phone: 800-987-3005
?
mi
from
Brewer, ME
Click here to add this to my saved trials
Chapel Hill, North Carolina 27599
Principal Investigator: Stuart H. Gold
Phone: 877-668-0683
?
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
171 Ashley Avenue
Charleston, South Carolina 29425
843-792-1414
Principal Investigator: Jacqueline M. Kraveka
Phone: 843-792-9321
Medical University of South Carolina The Medical University of South Carolina (MUSC) has grown from...
?
mi
from
Charleston, SC
Click here to add this to my saved trials
Charlotte, North Carolina 28204
Principal Investigator: Joel A. Kaplan
Phone: 800-804-9376
?
mi
from
Charlotte, NC
Click here to add this to my saved trials
1200 West Harrison Stree
Chicago, Illinois 60607
(312) 996-4350
Principal Investigator: Mary L. Schmidt
Phone: 312-355-3046
Univ of Illinois A major research university in the heart of one of the world's...
?
mi
from
Chicago, IL
Click here to add this to my saved trials
5841 S Maryland Ave
Chicago, Illinois 60637
1-773-702-6180
Principal Investigator: Ami V. Desai
Phone: 773-702-8222
University of Chicago Comprehensive Cancer Center The University of Chicago Comprehensive Cancer Center (UCCCC) is...
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Chicago, Illinois 60614
Principal Investigator: Stewart Goldman
?
mi
from
Chicago, IL
Click here to add this to my saved trials
2049 E 100th St
Cleveland, Ohio 44106
(216) 444-2200
Principal Investigator: Rabi Hanna
Phone: 866-223-8100
Cleveland Clinic Foundation The Cleveland Clinic (formally known as The Cleveland Clinic Foundation) is a...
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
10 Barnes West Drive
Creve Coeur, Missouri 63141
Principal Investigator: Robert J. Hayashi
Phone: 800-600-3606
?
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
Dallas, Texas 75390
Principal Investigator: Theodore W. Laetsch
Phone: 214-648-7097
?
mi
from
Dallas, TX
Click here to add this to my saved trials
Danville, Illinois 61832
Principal Investigator: James R. Egner
Phone: 800-446-5532
?
mi
from
Danville, IL
Click here to add this to my saved trials
Dayton, Ohio 45404
Principal Investigator: Ayman A. El-Sheikh
?
mi
from
Dayton, OH
Click here to add this to my saved trials
Denver, Colorado 80218
Principal Investigator: Jennifer J. Clark
Phone: 866-775-6246
?
mi
from
Denver, CO
Click here to add this to my saved trials
700 E University Ave
Des Moines, Iowa 50316
(515) 263-5612
Principal Investigator: Samantha L. Mallory
Phone: 515-241-8704
Iowa Lutheran Hospital Iowa Lutheran Hospital has a long history of serving the Des Moines...
?
mi
from
Des Moines, IA
Click here to add this to my saved trials
4160 John R St #2122
Detroit, Michigan 48201
(313) 833-1785
Principal Investigator: Roland L. Chu
Phone: 313-576-9790
Wayne State University/Karmanos Cancer Institute Karmanos is based in southeast Michigan, in midtown Detroit, and...
?
mi
from
Detroit, MI
Click here to add this to my saved trials
Detroit, Michigan 48236
Principal Investigator: Adonis N. Lorenzana
Phone: 734-712-3671
?
mi
from
Detroit, MI
Click here to add this to my saved trials
9333 Imperial Highway
Downey, California 90242
Principal Investigator: Robert M. Cooper
Phone: 510-891-3400
?
mi
from
Downey, CA
Click here to add this to my saved trials
2301 Erwin Rd
Durham, North Carolina 27710
919-684-8111
Principal Investigator: Lars M. Wagner
Phone: 888-275-3853
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
?
mi
from
Durham, NC
Click here to add this to my saved trials
Effingham, Illinois 62401
Principal Investigator: James R. Egner
Phone: 800-446-5532
?
mi
from
Effingham, IL
Click here to add this to my saved trials
El Paso, Texas 79905
Principal Investigator: Lisa L. Hartman
Phone: 915-298-5444
?
mi
from
El Paso, TX
Click here to add this to my saved trials
El Paso, Texas 79905
Principal Investigator: Lisa L. Hartman
Phone: 888-823-5923
?
mi
from
El Paso, TX
Click here to add this to my saved trials
Fontana, California 92335
?
mi
from
Fontana, CA
Click here to add this to my saved trials
Fort Myers, Florida 33908
Principal Investigator: Emad K. Salman
Phone: 877-680-0008
?
mi
from
Fort Myers, FL
Click here to add this to my saved trials
1600 Southwest Archer Road
Gainesville, Florida 32610
Principal Investigator: William B. Slayton
Phone: 352-273-8010
?
mi
from
Gainesville, FL
Click here to add this to my saved trials
1001 E 5th St
Greenville, North Carolina 27858
(252) 328-6131
Principal Investigator: Andrea R. Whitfield
Phone: 252-744-1015
East Carolina University Whether it's meeting the demand for more teachers and healthcare professionals or...
?
mi
from
Greenville, NC
Click here to add this to my saved trials
Greenville, South Carolina 29607
Principal Investigator: Robert D. Siegel
Phone: 864-255-1713
?
mi
from
Greenville, SC
Click here to add this to my saved trials
1 St. Francis Drive
Greenville, South Carolina 29601
864-255-1000
Principal Investigator: Robert D. Siegel
Phone: 864-255-1713
Saint Francis Hospital This 245-bed, all-private-room facility is located near downtown Greenville, South Carolina. Formerly...
?
mi
from
Greenville, SC
Click here to add this to my saved trials
900 West Faris Rd.
Greenville, South Carolina 29605
(864)455-8898
Principal Investigator: Nichole L. Bryant
BI-LO Charities Children's Cancer Center The BI-LO Charities Children
?
mi
from
Greenville, SC
Click here to add this to my saved trials
30 Prospect Ave
Hackensack, New Jersey 07601
(201) 996-2000
Principal Investigator: Katharine Offer
Phone: 201-996-2879
Hackensack University Medical Center Hackensack University Medical Center, part of the Hackensack University Health Network,...
?
mi
from
Hackensack, NJ
Click here to add this to my saved trials
2460 West Horizon Ridge Parkway
Henderson, Nevada 89052
Principal Investigator: Alan K. Ikeda
Phone: 702-822-2000
?
mi
from
Henderson, NV
Click here to add this to my saved trials
Honolulu, Hawaii 96819
Principal Investigator: Wade T. Kyono
Phone: 808-432-5195
?
mi
from
Honolulu, HI
Click here to add this to my saved trials
888 S King St
Honolulu, Hawaii 96813
(808) 522-4000
Principal Investigator: Wade T. Kyono
Phone: 808-522-4333
Straub Clinic And Hospital Founded in 1921, Straub Clinic & Hospital is a fully integrated...
?
mi
from
Honolulu, HI
Click here to add this to my saved trials
1319 Punahou St
Honolulu, Hawaii 96826
(808) 983-6000
Principal Investigator: Wade T. Kyono
Phone: 808-983-6090
Kapiolani Medical Center for Women and Children Hawai‘i Pacific Health is an integrated health care...
?
mi
from
Honolulu, HI
Click here to add this to my saved trials
Houston, Texas 77030
Principal Investigator: Jodi Muscal
Phone: 713-798-1354
?
mi
from
Houston, TX
Click here to add this to my saved trials
705 Riley Hospital Dr
Indianapolis, Indiana 46202
(317) 944-5000
Principal Investigator: Kamnesh R. Pradhan
Phone: 800-248-1199
Riley Hospital for Children Riley Hospital for Children at IU Health is a place of...
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Indianapolis, Indiana 46260
Principal Investigator: Bassem I. Razzouk
Phone: 317-338-2194
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Iowa City, Iowa 52242
Principal Investigator: Mariko Sato
Phone: 800-237-1225
?
mi
from
Iowa City, IA
Click here to add this to my saved trials
Jacksonville, Florida 32207
Principal Investigator: Scott M. Bradfield
?
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Kansas City, Missouri 64108
Principal Investigator: Kevin F. Ginn
?
mi
from
Kansas City, MO
Click here to add this to my saved trials
2018 W Clinch Ave
Knoxville, Tennessee 37916
(865) 541-8000
Principal Investigator: Ray C. Pais
Phone: 865-541-8266
East Tennessee Children's Hospital East Tennessee Children's Hospital is a not-for-profit, private, independent pediatric medical...
?
mi
from
Knoxville, TN
Click here to add this to my saved trials
La Crosse, Wisconsin
Principal Investigator: Kenneth B. De Santes
Phone: 608-775-2385
?
mi
from
La Crosse, WI
Click here to add this to my saved trials
Las Vegas, Nevada 89144
Principal Investigator: Alan K. Ikeda
Phone: 702-384-0013
?
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Las Vegas, Nevada 89109
Principal Investigator: Alan K. Ikeda
Phone: 702-384-0013
?
mi
from
Las Vegas, NV
Click here to add this to my saved trials
?
mi
from
Las Vegas, NV
Click here to add this to my saved trials
1 Medical Center Dr
Lebanon, New Hampshire 03756
 (603) 650-5000
Principal Investigator: Julie Kim
Phone: 800-639-6918
Dartmouth Hitchcock Medical Center Dartmouth-Hitchcock is a national leader in patient-centered health care and building...
?
mi
from
Lebanon, NH
Click here to add this to my saved trials
Lexington, Kentucky
Principal Investigator: Vlad C. Radulescu
Phone: 859-257-3379
?
mi
from
Lexington, KY
Click here to add this to my saved trials
1 Children's Way
Little Rock, Arkansas 72202
(501) 364-1100
Principal Investigator: David L. Becton
Phone: 501-686-8274
Arkansas Children's Hospital Arkansas Children's Hospital (ACH) is the only pediatric medical center in Arkansas...
?
mi
from
Little Rock, AR
Click here to add this to my saved trials
11234 Anderson St
Loma Linda, California 92354
(909) 558-4000
Principal Investigator: Albert Kheradpour
Phone: 909-558-3375
Loma Linda University Medical Center An outgrowth of the original Sanitarium on the hill in...
?
mi
from
Loma Linda, CA
Click here to add this to my saved trials
4733 Sunset Blvd
Los Angeles, California 90027
(800) 954-8000
Principal Investigator: Robert M. Cooper
Phone: 626-564-3455
Kaiser Permanente Los Angeles Medical Center We've been there for you in the past, providing...
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Louisville, Kentucky 40202
Principal Investigator: Kerry K. McGowan
Phone: 502-562-3429
?
mi
from
Louisville, KY
Click here to add this to my saved trials
Madera, California 93638
Principal Investigator: Vonda L. Crouse
?
mi
from
Madera, CA
Click here to add this to my saved trials
600 Highland Ave
Madison, Wisconsin 53792
(608) 263-6400
Principal Investigator: Kenneth B. De Santes
Phone: 800-622-8922
University of Wisconsin Hospital and Clinics UW Health strives to meet the health needs of...
?
mi
from
Madison, WI
Click here to add this to my saved trials
Mattoon, Illinois 61938
Principal Investigator: James R. Egner
Phone: 800-446-5532
?
mi
from
Mattoon, IL
Click here to add this to my saved trials
Miami, Florida 33155
Principal Investigator: Enrique A. Escalon
?
mi
from
Miami, FL
Click here to add this to my saved trials
Miami, Florida 33136
Principal Investigator: Julio C. Barredo
Phone: 305-243-2647
?
mi
from
Miami, FL
Click here to add this to my saved trials
9000 W Wisconsin Ave #270
Milwaukee, Wisconsin 53226
(414) 266-2000
Principal Investigator: Michael J. Burke
Phone: 414-955-4727
Children's Hospital of Wisconsin Nothing matters more than our children. At Children's Hospital of Wisconsin,...
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials
259 1st Street
Mineola, New York 11501
Principal Investigator: Mark E. Weinblatt
Phone: 866-946-8476
?
mi
from
Mineola, NY
Click here to add this to my saved trials
Minneapolis, Minnesota 55455
Principal Investigator: Emily G. Greengard
Phone: 612-624-2620
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
2525 Chicago Ave
Minneapolis, Minnesota 55404
(612) 813-6000
Principal Investigator: Michael K. Richards
Children's Hospitals and Clinics of Minnesota - Minneapolis Children's Hospitals and Clinics of Minnesota is...
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Morristown, New Jersey 07962
Principal Investigator: Steven L. Halpern
Phone: 973-971-5900
?
mi
from
Morristown, NJ
Click here to add this to my saved trials
Nashville, Tennessee 37203
Principal Investigator: Haydar A. Frangoul
Phone: 800-811-8480
?
mi
from
Nashville, TN
Click here to add this to my saved trials
New Brunswick, New Jersey 08903
Principal Investigator: Jocelyn A. Lewis
Phone: 732-235-8675
?
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
New Haven, Connecticut 6520
(203) 432-4771
Principal Investigator: Nina S. Kadan-Lottick
Phone: 203-785-5702
Yale University Yale's roots can be traced back to the 1640s, when colonial clergymen led...
?
mi
from
New Haven, CT
Click here to add this to my saved trials
New Hyde Park, New York 11040
Principal Investigator: Julie I. Krystal
?
mi
from
New Hyde Park, NY
Click here to add this to my saved trials